|
C17ORF75 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.20980000356741E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.12359999970835E-07 |
| Normal-vs-Stage2 |
1.712620E-01 |
| Normal-vs-Stage3 |
1.82900000000874E-06 |
| Normal-vs-Stage4 |
1.00089999954811E-07 |
| Stage1-vs-Stage2 |
4.763900E-02 |
| Stage1-vs-Stage3 |
9.307400E-01 |
| Stage1-vs-Stage4 |
4.166400E-01 |
| Stage2-vs-Stage3 |
6.614000E-02 |
| Stage2-vs-Stage4 |
2.096400E-02 |
| Stage3-vs-Stage4 |
4.178200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.62239996174208E-09 |
| Normal-vs-AfricanAmerican |
2.132800E-01 |
| Normal-vs-Asian |
2.36859999946937E-07 |
| Caucasian-vs-AfricanAmerican |
1.343580E-02 |
| Caucasian-vs-Asian |
3.893200E-01 |
| AfricanAmerican-vs-Asian |
4.522300E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.68010000023422E-07 |
| Normal-vs-Female |
1.21430000055156E-07 |
| Male-vs-Female |
4.326400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.46340000006795E-07 |
| Normal-vs-Age(41-60Yrs) |
4.28060000001729E-07 |
| Normal-vs-Age(61-80Yrs) |
1.034960E-04 |
| Normal-vs-Age(81-100Yrs) |
3.440600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.748200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.217180E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.200600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.652800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.732400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.225000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.563600E-01 |
| Classical-VS-Follicular |
1.588470E-02 |
| Classical-VS-Other |
5.771800E-01 |
| Classical-VS-Normal |
1.49649999947599E-07 |
| Tall-VS-Follicular |
9.642600E-03 |
| Tall-VS-Other |
9.268600E-01 |
| Tall-VS-Normal |
2.80460000001703E-06 |
| Follicular-VS-Other |
2.323600E-01 |
| Follicular-VS-Normal |
2.529900E-02 |
| Other-VS-Normal |
5.415600E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.84259999997028E-06 |
| Normal-vs-N1 |
9.58370000025965E-08 |
| N0-vs-N1 |
5.886100E-02 |
|
|
